This spontaneous case was reported by a patient family member or friend and describes the occurrence of COVID-19 (Tested positive for Covid 19 after receiving 2 primary doses and 1 booster dose of the Moderna Covid 19 vaccine) in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032F21A, 032M20A and 032M20A) for COVID-19 vaccination. The patient had no allergies. Concurrent medical conditions included Disability (he has a disability, but is not immunocompromised) and ADHD. Concomitant products included DEXMETHYLPHENIDATE for ADHD. On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Aug-2022, the patient experienced COVID-19 (Tested positive for Covid 19 after receiving 2 primary doses and 1 booster dose of the Moderna Covid 19 vaccine). At the time of the report, COVID-19 (Tested positive for Covid 19 after receiving 2 primary doses and 1 booster dose of the Moderna Covid 19 vaccine) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Aug-2022, SARS-CoV-2 test: (Positive) Positive. Patient mother would want to know that her son was eligible to receive a booster dose of the Moderna COVID 19 vaccine. She mentioned that she and her son had a recent COVID-19 infection. The symptoms were started on Monday 15-Aug-2022. Treatment medications were not reported. Company comment: This spontaneous case concerns a male patient aged 24 years with no relevant medical history reported, who experienced the unexpected non-serious AESI of Covid 19 ( with a positive SARS-CoV-2 test) that occurred approximately 9 months after first booster dose of mRNA-1273 vaccination. Patient had received initial two doses of same vaccine at an interval of 28 days and first booster after 8 months. No further information on risk factors, detailed clinical course, treatment received was available in the report. Patients mother also had a recent Covid infection. Outcome of the event Covid 19 was unknown at the time of report. The current pandemic situation of COVID 19 may remain as confounder to the event Covid-19. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report. Event seriousness (non-serious) assessed as per medical judgement and available information. This case was linked to MOD-2022-638957 (Patient Link). Sender's Comments: This spontaneous case concerns a male patient aged 24 years with no relevant medical history reported, who experienced the unexpected non-serious AESI of Covid 19 ( with a positive SARS-CoV-2 test) that occurred approximately 9 months after first booster dose of mRNA-1273 vaccination. Patient had received initial two doses of same vaccine at an interval of 28 days and first booster after 8 months. No further information on risk factors, detailed clinical course, treatment received was available in the report. Patients mother also had a recent Covid infection. Outcome of the event Covid 19 was unknown at the time of report. The current pandemic situation of COVID 19 may remain as confounder to the event Covid-19. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report. Event seriousness (non-serious) assessed as per medical judgement and available information.